Wide vs narrow breast surgery margins after lumpectomy
Treatments studied
Part of Cancer, Skin clinical trials.
This study compares two ways of cutting the edge (margin) of tissue during lumpectomy after breast cancer treatment. It may help reduce the chance of the cancer coming back locally by testing whether a wider margin is better than a narrow one.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer diagnosis is confirmed by biopsy and is invasive adenocarcinoma
- Your tumor size/stage is T1 to T4b, and lymph nodes are N0 to N2
- You are generally healthy for surgery (ASA class I or II)
- You plan to have a lumpectomy (not mastectomy)
- Your cancer is not spread to other organs (not metastatic)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This study compares two ways surgeons take “margin” samples (tissue from the edge of the tumor area) during breast-conserving surgery for early breast cancer. It uses a guidance device to help collect these samples and aims to see which approach better supports safe, effective treatment.
This study compares two different surgical approaches for removing early-stage breast cancer while preserving the breast. You may qualify if you have a single, small tumor and want to keep your breast.
This trial compares two types of breast-conserving surgery: one done with small cuts and a camera (laparoscopic) and the traditional open method. It looks at safety and how the breast looks afterward, to see if the newer method works as well or better.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.